Most Common Malignant Tumor of Salivary Glands
Mucoepidermoid carcinoma is the most common malignant tumor of the salivary glands.
Epidemiologic Evidence
The predominance of mucoepidermoid carcinoma among salivary gland malignancies is well-established across multiple studies:
In a large National Cancer Database study of 4,431 patients with parotid gland malignancies, mucoepidermoid carcinoma was the most frequently encountered malignant histology 1
A tertiary care hospital study found mucoepidermoid carcinoma accounted for 62.5% of all malignant salivary gland tumors, making it by far the most common malignancy 2
In a surgical series of 407 salivary gland neoplasms, mucoepidermoid carcinoma (12.7%) was the second most common malignancy after adenoid cystic carcinoma (28.2%), though this represents a single-center experience 3
Clinical Context
Mucoepidermoid carcinoma most commonly affects the parotid gland, as approximately 80% of all salivary gland tumors (benign and malignant) occur in the parotid, with 10% in submandibular glands and the remainder in minor salivary glands 2
Prognostic Factors
Survival in mucoepidermoid carcinoma is significantly influenced by:
- Tumor grade (low, intermediate, or high-grade histology) 1
- Pathologic stage at presentation 1
- Surgical margin status 1
- Patient age and comorbidities 1
Important Caveat
While mucoepidermoid carcinoma is the most common malignant salivary gland tumor overall, adenoid cystic carcinoma (ACC) deserves special mention because it has unique clinical behavior with propensity for late pulmonary metastases and prolonged survival even with metastatic disease 1. ACC patients can survive more than 10 years despite having distant metastases, requiring extended surveillance beyond 5 years 1.